Effect of the Combination of Plant Extracts (BSL_EP025) in Cardiovascular Health
Pilot Study to Evaluate the Effect of the Consumption of a Combination of Plant Extracts (BSL_EP025) on the Levels of LDL-cholesterol and Oxidized LDL-cholesterol in Healthy Volunteers
1 other identifier
interventional
40
1 country
1
Brief Summary
The objective of the study is to evaluate the ability of a combination of plant extracts (BSL\_EP025) to reduce the levels of LDL-cholesterol and oxidized LDL-cholesterol in individuals with LDL-cholesterol levels between 100 and 190 mg/dL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 24, 2019
CompletedFirst Submitted
Initial submission to the registry
July 22, 2019
CompletedFirst Posted
Study publicly available on registry
July 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2019
CompletedNovember 15, 2019
July 1, 2019
2 months
July 22, 2019
November 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
LDL cholesterol
Levels of LDL cholesterol in plasma
8 weeks
Oxidized LDL cholesterol
Levels of oxidized LDL cholesterol in plasma
8 weeks
Secondary Outcomes (11)
Total cholesterol
8 weeks
HDL cholesterol
8 weeks
Triglycerides
8 weeks
Glucose
8 weeks
Blood pressure
8 weeks
- +6 more secondary outcomes
Study Arms (2)
Combination of Plant Extracts (BSL_EP025)
EXPERIMENTALThe volunteers will take two capsules daily with a combination of plant extracts (BSL\_EP025)
Placebo
PLACEBO COMPARATORThe volunteers will take two capsules daily with maltodextrin.
Interventions
Each participant will consume 2 capsules daily at lunch for 8 weeks.
Each participant will consume 2 capsules daily at lunch for 8 weeks.
Eligibility Criteria
You may qualify if:
- Men or women between 18 and 65 years of age.
- Levels of LDL-cholesterol between 100 and 190 mg/dL.
- Accept freely to participate in the study and sign the informed consent document.
You may not qualify if:
- Be pregnant.
- Have planned to carry out a dietary intervention or exercise practice with the aim of losing weight in the coming weeks.
- Suffer from a serious illness.
- Have diabetes.
- Having a cerebrovascular disease.
- Be taking products or drugs to control cholesterol levels or with antioxidant activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Biosearch S.A.lead
Study Sites (1)
Biosearch Life
Granada, Andalusia, 18004, Spain
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Miguel Quesada, MD, PhD
Medical specialist in Endocrinology, Hospital San Cecilio de Granada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2019
First Posted
July 23, 2019
Study Start
May 24, 2019
Primary Completion
July 31, 2019
Study Completion
July 31, 2019
Last Updated
November 15, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share